This Summit Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Friday

Centene Corporation CNC	0.00	0.00%
ENDAVA LTD DAVA	0.00	0.00%
Summit Therapeutics Inc SMMT	0.00	0.00%
Texas Instruments Incorporated TXN	0.00	0.00%
Zoom Video Communications ZM	0.00	0.00%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

HC Wainwright & Co. analyst Mitchell S. Kapoor downgraded Summit Therapeutics Inc (NASDAQ:SMMT) from Buy to Neutral. Summit Therapeutics shares closed at $17.47 on Thursday. See how other analysts view this stock.
JP Morgan analyst Puneet Jain downgraded Endava PLC – ADR (NYSE:DAVA) from Neutral to Underweight and lowered the price target from $9 to $5. Endava shares closed at $3.34 on Thursday. See how other analysts view this stock.

Considering buying SMMT stock? Here’s what analysts think:

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.